Neuronal L-type calcium channels contribute to dendritic excitability and activity-dependent changes in gene expression that influence synaptic strength. Phosphorylation-mediated enhancement of L-type channels containing the Ca V 1.2 pore-forming subunit is promoted by A-kinase anchoring proteins (AKAPs) that target cAMP-dependent protein kinase (PKA) to the channel. Although PKA increases L-type channel activity in dendrites and dendritic spines, the mechanism of enhancement in neurons remains poorly understood. Here, we show that Ca V 1.2 interacts directly with AKAP79/150, which binds both PKA and the Ca 2+ /calmodulin-activated phosphatase calcineurin (CaN). Cotargeting of PKA and CaN by AKAP79/150 confers bidirectional regulation of L-type current amplitude in transfected HEK293 cells and hippocampal neurons. However, anchored CaN dominantly suppresses PKA enhancement of the channel. Additionally, activation of the transcription factor NFATc4 via local Ca 2+ influx through L-type channels requires AKAP79/150, suggesting that this signaling complex promotes neuronal L channel signaling to the nucleus through NFATc4.
INTRODUCTION
The activity of voltage-gated L-type Ca 2+ channels is tuned by cAMP (Reuter, 1967; Tsien et al., 1972) . This form of ion channel modulation has been extensively studied in heart, where it is prominent in the control of cardiac rate and contractility. In neurons, L-type Ca 2+ channels are subject to a similar kind of modulation (Gray and Johnston, 1987) , but the phenomenon has received much less attention in these cells. Phosphorylation of Ca V 1.2-based L-type channels by cAMP-dependent kinase (PKA) enhances L-type Ca 2+ currents by increasing the opening probability of individual channels (Bean et al., 1984; Yue et al., 1990) . Considerable evidence indicates that enhancement of current occurs in response to PKAmediated phosphorylation of Ser1928 in the C-terminal tail of the pore-forming Ca V 1.2 subunit (reviewed by Catterall, 2000) , although additional sites on the Ca V 1.2 subunit (Ganesan et al., 2006) and the Ca V b subunit (Bunemann et al., 1999) have been implicated in this regulation as well.
In dendrites of hippocampal pyramidal neurons, PKA activation by cAMP enhances L-type channel current (Hoogland and Saggau, 2004; Kavalali et al., 1997) . In these neurons, two L-type channel isotypes are present, but Ca V 1.2 channels outnumber Ca V 1.3 channels by nearly 4:1 (Hell et al., 1993) , and Ca V 1.2 channels have been identified in macromolecular complexes containing b 2 adrenergic receptors, adenylyl cyclases, and PKA (Davare et al., 2001) , observations that together suggest that Ca V 1.2 is likely to be a dominant isotype under the control of cAMP in hippocampal pyramidal neurons. L-type channels contribute about half of the total voltage-gated Ca 2+ current in hippocampal pyramidal neurons (Mintz et al., 1992) , and they are thought to participate in the control of dendritic excitability and help couple neuronal excitation to transcription of Ca 2+ -regulated genes (Bading et al., 1993; Dolmetsch et al., 2001; Graef et al., 1999; Impey et al., 1996; Mermelstein et al., 2000; Murphy et al., 1991) . Postsynaptic L-type Ca 2+ channels are critical in initiating long-lasting changes in synaptic strength that are dependent upon protein synthesis but independent of NMDA receptor activation (Grover and Teyler, 1990) . Accordingly, knockout in hippocampus and neocortex of the Ca V 1.2 L-type channel impairs both NMDA receptor-independent late-phase LTP and hippocampus-dependent spatial learning (Moosmang et al., 2005) . In contrast, knockout of the other major L-type channel isotype in brain, Ca V 1.3, has no effect on either synaptic plasticity or learning (Clark et al., 2003) .
Many PKA substrates depend upon A-kinase anchoring proteins (AKAPs) for efficient phosphorylation by PKA. It has recently emerged that AKAPs often anchor PKA directly to the phosphorylation target, helping to explain how PKA can act specifically despite its wide array of substrates. Thus, modulation by PKA of cardiac and skeletal muscle Ca 2+ channels requires a modified leucine zippermediated interaction between AKAP15 (also known as AKAP18) and the a 1 subunit of these channels (Hulme et al., 2002 (Hulme et al., , 2003 . But while AKAP15 directs PKA alone to substrates, other AKAPs act as signaling integrators by binding additional regulators of PKA targets. AKAP79/150 (79 human/150 rodent) is the prototypical example of a multivalent anchoring protein, simultaneously binding PKA and the calcium-calmodulin (Ca 2+ / CaM)-activated phosphatase calcineurin (CaN; protein phosphatase 2B) (Oliveria et al., 2003) . This AKAP79/ 150-based complex bearing an opposed kinase and phosphatase is present in the postsynaptic density within dendritic spines of neurons (Colledge et al., 2000; Klauck et al., 1996) . AKAP79/150 has emerged as an important organizer of signaling events underlying excitatory synaptic plasticity, for example in the control of AMPA receptor downregulation during long-term synaptic depression (reviewed by Bauman et al., 2004) . While it has been previously demonstrated that coexpression of AKAP79 with Ca V 1.2 promotes PKA phosphorylation of the channel in HEK293 cells (Gao et al., 1997) , past work has not addressed the role of CaN anchoring in channel modulation nor whether AKAP79/150 is involved in regulation by PKA of L-type channels in neurons.
Here, we demonstrate that AKAP79/150-anchored CaN controls neuronal L-type Ca 2+ channel activity and is also critical for at least one form of L channel-dependent signaling to the nucleus. We show that endogenous AKAP150 and Ca V 1.2 are present together in macromolecular complexes isolated from cultured hippocampal neurons and that reconstitution of this complex in HEK293 cells requires a direct interaction between modified leucine zipper motifs in both proteins. We show that, in neurons, enhancement of L-type current by PKA requires anchoring of this kinase by AKAP79/150. Our results reveal a powerful opposition to PKA by CaN, which profoundly attenuates enhancement of channel current. We also demonstrate that AKAP79/150 targeting of CaN is necessary to couple Ca 2+ influx via L-type channels to activation of the transcription factor NFATc4. Our results suggest that, like the interaction between CaM and the proximal portion of the Ca V 1.2 C terminus that underlies both Ca 2+ -dependent channel inactivation and control of nuclear signaling through cyclic AMP response element binding protein (CREB), the AKAP79/150 interaction with the distal C terminus of the channel confers two distinct properties on neuronal L-type Ca 2+ channels: reciprocal regulation of channel phosphorylation by CaN and PKA and control of downstream signaling to the nucleus through NFATc4. (Hulme et al., 2002 (Hulme et al., , 2003 , we examined the possibility that neuronal Ca V 1.2 channels might reside with AKAP150 in a macromolecular complex. Using extracts from cultured rat hippocampal neurons, we found that a well-characterized antibody directed against the distal C terminus of Ca V 1.2 (Gao et al., 2001 ) immunoprecipitated (IP'd) AKAP150 along with the channel (Figure 1A) . Likewise, an antibody directed against AKAP150 IP'd full-length (>200 kDa) Ca V 1.2 along with AKAP150, indicating that AKAP150 and Ca V 1.2 are present together in macromolecular complexes in neurons. AKAP15 associates with Ca V 1.1 in skeletal muscle and with Ca V 1.2 in cardiac muscle through a modified leucine zipper (LZ) interaction (Hulme et al., 2002 (Hulme et al., , 2003 . Examination of the amino acid sequences of AKAP79/150 reveals a similar motif of conserved, heptad-spaced hydrophobic residues in the C termini of these homologs as well (Figure 1B, top) . To test whether Ca V 1.2 interacts closely, perhaps directly, with AKAP79/150, we used fluorescence resonance energy transfer (FRET) measurements from HEK293 cells cotransfected with AKAP79 fused to enhanced cyan fluorescent protein (AKAP79-CFP) and Ca V 1.2 fused to enhanced yellow fluorescent protein (Ca V 1.2-YFP). In HEK293 cells transfected with this pair of fluorescent constructs, we estimated FRET using two independent approaches: a three-filter-based method that yields corrected, sensitized FRET images (FRET C , 3F) and a donor-dequenching method based on acceptor photobleaching (PB) ( Figures 1C and 1D ). Images of HEK293 cells coexpressing Ca V 1.2-YFP and AKAP79-CFP tagged on its C terminus (wt-C) showed extensive colocalization of the channel and AKAP at the plasma membrane ( Figure 1C , top row). Further, a strong, membrane-localized FRET C signal was evident in these cells;
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images of FRET C gated to the energy donor's signal intensity, FRET C (CFP), are presented on a pseudocolor-coded intensity scale. The energy transfer efficiency (E eff ) at the plasma membrane was calculated using information from the CFP, YFP, and raw FRET images (black bars in Figure 1D ) and, alternatively, from acceptor photobleach measurements of FRET carried out subsequently in the same cells (gray bars in Figure 1D ). Additional FRET data and analysis are presented in Figure S1 in the Supplemental Data available with this article online.
In cells coexpressing Ca V 1.2-YFP and N-terminaltagged AKAP79-CFP (wt-N), imaging revealed that the channel and AKAP were again colocalized at the plasma membrane. For this fluorescent pair, however, no energy transfer was detectable. The absence of FRET in this case presumably reflects either an increased spatial separation between the fluorescent moieties or an unfavorable orientation between them. Neither colocalization nor FRET were observed when only the membranetargeting domain of AKAP79 (residues 1-153) was coexpressed with Ca V 1.2, indicating that the C-terminal portion of AKAP79 is necessary for association with Ca V 1.2 at the plasma membrane. To specifically probe the role of the modified LZ motif of AKAP79 in the interaction with Ca V 1.2, we introduced point mutations at two positions in the anchoring protein (Figure 1B, bottom; Hulme et al., 2003) . Energy transfer between this C-terminal-tagged 79LZm-CFP mutant and Ca V 1.2-YFP was significantly (Gao et al., 1997) and that protein phosphatase 2A opposes the effect of PKA on Ba 2+ currents carried by Ca V 1.2 (Hall et al., 2006) . However, AKAP79/150 is known to cobind PKA and the Ca 2+ /CaM-activated phosphatase CaN (Oliveria et al., 2003) . To test whether CaN shares in the regulation of L-type channel activity, we allowed CaN activation via Ca 2+ influx (rather than Ba 2+ ) through Ca V 1.2 channels, and we dialyzed cells intracellularly with 10 mM EGTA, which allows rises in Ca 2+ concentration only in the vicinity of the channel Marty and Neher, 1985) . While cAMP was elevated with forskolin (FSK), we acutely disrupted PKA anchoring by applying in the extracellular solution a stearated, membranepermeant peptide, St-Ht31, which resembles the AKAP79 binding site for PKA (Carr et al., 1992; Snyder et al., 2005) . In HEK293 cells transfected with Ca V 1.2 channel subunits and AKAP79-YFP, application of StHt31 caused a rapid decrease in whole-cell Ca 2+ current amplitude (Figures 2A and 2B) , as though channel phosphorylation and current enhancement by PKA were diminished by loss of PKA from the AKAP79/Ca V 1.2 complex (nonstearated Ht31 had a similar effect when included in the pipette solution; Figure S2 ). No decrease in current amplitude was observed when an inactive form of the peptide (St-Ht31 pro ) was applied, and the effect of St-Ht31 was much smaller in the absence of FSK. In FSK-stimulated cells transfected with LZm mutants of AKAP79 and Ca V 1.2, current amplitude was unaffected by St-Ht31. Substitution of alanine at the putative site of PKA phosphorylation (S1928) also occluded St-Ht31 action ( Figure 2C ). The occlusion of St-Ht31 action by mutations in the LZm domains or at S1928 are consistent with the ideas that the LZm domains sustain channel-AKAP interaction that is needed for efficient phosphorylation of the channel and that S1928 is a critical target of phosphorylation by PKA.
The Effect on Ca V 1.2 of Disruption of PKA Anchoring Requires CaN Anchoring to a PXIXIT-like Motif We have previously identified a CaN binding region in AKAP79 between residues 315 and 360, and within this region is a motif (PIAIIIT; residues 337-343) that resembles the consensus sequence for CaN binding (PXIXIT) . To test whether this motif represents the core of the CaN binding site in AKAP79, we coexpressed AKAP79-CFP and CaNA-YFP in COS7 cells. Deletion of the 7 residues composing the PXIXIT-like motif (79DPIX) disrupted both AKAP79 targeting of CaN to membrane structures and FRET between AKAP79-CFP and CaNA-YFP ( Figures 2D and 2E) . Deletion of the PXIXIT-like motif was as effective in disrupting coIP of AKAP79 with myc-tagged CaNA as was deleting the entire CaN binding region (residues 315-360; 79DCaN) ( Figure 2F ).
We next tested whether CaN activity was responsible for decreasing current amplitude after disruption of PKA anchoring. St-Ht31 had no effect on FSK-stimulated cells expressing either 79DCaN-YFP or the 79DPIX-YFP (Figures 2G and 2H) and was also ineffective in the presence of the CaN inhibitor cyclosporin A (CsA). We conclude that St-Ht31 decreases Ca V 1.2 current amplitude by promoting unopposed dephosphorylation of Ca V 1.2 by AKAP79-anchored CaN.
VIVIT Disrupts CaN Anchoring and Reveals
Opposition to Enhancement of Ca V 1.2 by PKA To further probe the role of AKAP79/150-anchored CaN in the regulation of Ca V 1.2 channels, we sought a molecular tool analogous to Ht31 that would disrupt CaN binding to AKAP79/150 but not inhibit the enzyme's phosphatase activity. Recently, the VIVIT peptide has been shown to disrupt CaN binding to a PXIXIT-docking motif in NFAT transcription factors without inhibiting the phosphatase (Aramburu et al., 1999; Li et al., 2004) . The presence of a PXIXIT-like motif in AKAP79/150 suggested that VIVIT might be effective in disrupting binding of CaN to AKAP79/150. To test the applicability of VIVIT in our system, we first studied the effect of expressing VIVIT-GFP in cells transfected with AKAP150 and myc-tagged CaNA. As shown in Figure 3A , coIP of AKAP150 with myc-CaNA was prevented by VIVIT-GFP. Immunostaining of COS7 cells transfected with AKAP79 and myc-CaNA shows that expression of VIVIT-GFP also disrupts anchoring of CaN to membrane structures by AKAP79 (Figure 3B ). These data suggested that VIVIT competitively disrupts CaNA binding to AKAP79/150, at least when chronically present in cells.
To test whether CaN anchoring to AKAP79 is important for regulation of Ca V 1.2 we applied stearated VIVIT extracellularly to acutely disrupt the AKAP79-CaN interaction. Perfusion of St-VIVIT increased current amplitude rapidly after FSK stimulation, but not in cells expressing 79DPIX-YFP, indicating that St-VIVIT specifically competes for binding to the PXIXIT-like motif of AKAP79 and that anchored CaN opposes enhancement by PKA of Ca V 1.2 current (Figures 3C and 3D; nonstearated VIVIT had a similar effect when included in the pipette solution, Figure S2 ). St-VIVIT had a small effect in the absence of FSK that likely reflects the effect of basal PKA activity on the channel after CaN anchoring is disrupted. St-VIVIT had no effect on FSK-stimulated cells when PKA binding to AKAP79 was disturbed (79PKA pro2 , which disrupts the helical structure of the PKA binding site; a similar result was also observed with wild-type Ca V 1.2 and AKAP79 when Ht31 was included in the pipette, data not shown), or when cells were exposed to the PKA inhibitor PKI. Similar to St-Ht31, the effect of St-VIVIT also required an intact LZ interaction and the S1928 phosphorylation site ( Figure 3E ), suggesting that St-VIVIT application increases current amplitude by permitting unopposed PKA to phosphorylate the channel at S1928. Marty and Neher, 1985) . When Ba 2+ replaced extracellular Ca 2+ , increasing depolarization frequency from 0.2 Hz to 1 Hz still caused current amplitude to drop, although more slowly and to a lesser degree than in Ca 2+ ( Figure S3 ). As in Ca 2+ , the de-enhancement that was observed in Ba 2+ was prevented by the CaN autoinhibitory peptide, indicating that , gray squares), the Ca V 1.2 phosphorylation site mutant S1928A and wild-type AKAP79 (S1928A, black hexagons), or to cells expressing wild-type Ca V 1.2 and AKAP79 preincubated with the PKA inhibitor PKI (PKI, gold triangles). Small dots reproduce the control condition shown in (D) as red circles.
Ba
2+ is able to act as an agonist for CaM activation of CaN. Ba 2+ and other divalent metal cations are capable of acting as weak agonists for several CaM-dependent processes (Artalejo et al., 1996; Gu and Cooper, 2000; Hardcastle et al., 1983; Proks and Ashcroft, 1995) . In sharp contrast, Ba 2+ is unable to substitute for Ca 2+ in triggering Ca 2+ -dependent inactivation of voltage-gated Ca 2+ channels (Erickson et al., 2003; Tillotson, 1979; Zuhlke et al., 1999) . Taken together with the observation that 10 mM BAPTA prevents current de-enhancement in Ca 2+ , the result that Ba 2+ partially supports de-enhancement further indicates that channel de-enhancement in response to increased depolarization frequency is due to CaN dephosphorylation and not Ca 2+ -dependent inactivation, because the latter process is absent in Ba 2+ but intact in BAPTA (Cens et al., 1999; Zuhlke et al., 1999 Figure 3D ). The dynamic range of modulation we have observed, >3-fold enhancement (from $40% to $130%) above our measured minimum, is much larger than has been described previously for the reconstituted HEK293 cell system and approaches the range of L channel modulation found in cardiac myocytes.
Anchored CaN Opposes the Effect of PKA on L-Type Current Amplitude in Hippocampal Neurons
In hippocampal neurons, Ca V 1.2 has been shown to be important for memory and NMDA receptor-independent plasticity (Moosmang et al., 2005) , and Ca 2+ influx through L-type channels is enhanced by activation of b 2 -adrenergic receptors in dendritic spines of these neurons (Hoogland and Saggau, 2004) . To test whether AKAP150 anchoring is important for local modulation of neuronal L-type channels, we examined pharmacologically isolated, voltage-clamped L-type Ca 2+ current in mature cultured hippocampal neurons dialyzed intracellularly with 10 mM EGTA. Despite the difficulty of properly spaceclamping L-type current in these extensively arborized neurons, plots of peak Ca 2+ current exhibited highly reproducible responses to experimental manipulation of PKA and CaN. In the absence of FSK, there was no difference between control time courses for L-type Ca 2+ currents and those recorded with Ht31 in the patch pipette. However, intracellular dialysis of VIVIT resulted in an increase in current amplitudes without PKA stimulation ( Figure 5A ). This effect of VIVIT was blunted when PKI was simultaneously dialyzed into the cell, and CsA closely mimicked the effect of VIVIT ( Figure 5B ). When FSK was included in the pipette solution, there was a small amount of current enhancement, which was prevented by Ht31, revealing an anchoring-dependent enhancement of L-type current by PKA ( Figure 5C ). However, the more prominent consequence of adding FSK to the pipette was that the effects of both VIVIT and CsA were substantially augmented ( Figures  5C and 5D ), suggesting that anchored CaN strongly opposes PKA phosphorylation of the channel even in the presence of elevated cAMP production. Additionally, simultaneous dialysis of PKI blunted the effect of VIVIT to the same extent in the presence of FSK as it had without FSK, indicating that while there may be a small amount of L-type channel phosphorylation by kinases other than PKA when CaN anchoring is disrupted, the effect of VIVIT on L-type currents is mainly the result of removing opposition to PKA activity.
The Effects of PKA and CaN on Neuronal L-Type Channels Are Specific to AKAP79/150
Ht31 competes with all AKAPs for PKA binding, and VIVIT competes with any protein bearing a PXIXIT-like motif for CaN binding. To test whether the anchoring-dependent effects of PKA and CaN are specific to AKAP150 in hippocampal neurons, we used an RNAi knockdown and rescue approach (Hoshi et al., 2005) . We cotransfected neurons with GFP and a short hairpin construct that specifically interferes with expression of endogenous AKAP150 but not human AKAP79. Transfected neurons, marked by GFP expression, were reliably deficient in AKAP150 immunostaining when compared to untransfected neurons growing in the same cultures ( Figure 6A, top) . Coexpression of AKAP79-GFP with the AKAP150 RNAi construct was also successful, effectively resulting in replacement of the endogenous rat anchoring protein by the human form ( Figure 6A , bottom). When hippocampal pyramidal neurons were transfected with the AKAP150 RNAi construct, the effect of VIVIT on L-type current in untransfected cells was abolished whether or not FSK was included in the pipette (Figures 6B and 6C) . FSK did cause a small enhancement of current that may represent the activity of PKA associated with other AKAPs or of nonanchored PKA. In contrast, cotransfection of AKAP79-GFP and the AKAP150 RNAi construct substantially enhanced the effect of VIVIT + FSK compared to untransfected cells. Cotransfection with the 79DPIX-GFP mutant increased the sensitivity of endogenous L-type channels to FSK, yielding a time course that closely resembles the time course of the effect of VIVIT + FSK in the AKAP79-GFP rescue condition (Figures 6B and 6D ). These data indicate that the effects of PKA and CaN on L-type channels in hippocampal pyramidal neurons are specific to AKAP79/150 anchoring and that CaN associates with and modulates neuronal L-type channels specifically through its association with the PXIXIT-like motif of AKAP79/150. 
AKAP79/150 Couples Neuronal L-Type Channel Activity to NFATc4 Activation
In cultured hippocampal pyramidal neurons, Ca 2+ entry specifically via L-type Ca 2+ channels activates CaN, which in turn stimulates translocation to the nucleus of the transcription factor NFATc4 (Graef et al., 1999 Figure 7A ). NFATc4 translocation to the nucleus required L-type channel activity, as changes in NFATc4 distribution were not observed when the L channel blocker nimodipine was present during the stimulation protocol. Nor was nuclear translocation of NFATc4 observed in neurons transfected with an RNAi construct that knocked down expression of native AKAP150 (Figures 7B and 7C ). NFATc4 translocation was rescued in AKAP150 knockdown neurons by cotransfection with AKAP79, the human homolog of AKAP150. Cotransfection with the AKAP79DPIX mutant failed to rescue NFATc4 translocation, despite this mutant's ability to support PKA enhancement of Ca V 1.2 ( Figure 6D ) and its intact interaction with the channel (current density in Table S1 , also unpublished data showing intact FRET).
These findings support the hypothesis that neuronal activity is coupled to downstream activation of NFATc4 by AKAP79/150 targeting of CaN to L-type channels. This hypothesis predicts that nuclear translocation of NFATc4 depends upon activation of CaN by localized [Ca 2+ ] increases near L channels. To test the prediction, we loaded neurons with equal concentrations of either the slow Ca 2+ chelator EGTA or the faster Ca 2+ chelator BAPTA. Consistent with the prediction and our finding that only EGTA-insensitive, short-range [Ca 2+ ] signals trigger CaN control of channel activity in HEK293 cells and neurons, NFATc4 translocation in neurons was unaffected by EGTA but powerfully suppressed by BAPTA ( Figure 7D ). These results indicate that the pool of CaN and its initiating NFATc4 signaling reside <2 mm from the mouth of neuronal L-type channels Marty and Neher, 1985) . We considered the possibility that PKA anchored to L channels by AKAP79/150 might oppose activation of NFATc4 by CaN, because activation of PKA has been reported to phosphorylate NFATc4 and suppress its nuclear translocation in neurons (Belfield et al., 2006) . We found that inhibition of PKA by myristoylated PKI greatly enhanced the response of NFATc4 to stimulation with high [K + ] ( Figure 7E ). However, disruption by St-Ht31 of PKA anchoring to AKAP only modestly enhanced NFATc4 translocation relative to control, suggesting that although PKA opposes CaN activation of NFATc4, it is unanchored PKA that likely carries out this task.
DISCUSSION
Ca V 1.2 L-type Ca 2+ channels can physically associate with either AKAP79/150 or AKAP15 through a modified leucine zipper interaction, but both the modulation of the channel and its downstream signaling depend upon the identity of the associated AKAP. Thus, both of these AKAPs target PKA to the channel, but AKAP79/150 also targets CaN and thereby confers unique characteristics upon AKAP79/150-complexed L-type channels in neurons (Figure 8 ).
Anchored CaN is so effective that its action on L channels should not be thought of as only a reversal of PKAmediated enhancement. Instead, CaN powerfully suppresses enhancement, even in the presence of elevated cAMP. The converse is true of Ca 2+ -permeable AMPA receptors that are associated with AKAP79/150, where a clear effect of CaN is only revealed upon disruption of PKA anchoring or activity (Hoshi et al., 2005; Tavalin et al., 2002) . The dominance of CaN in the L channel-AKAP79/150 complex may originate in the microenvironment near the intracellular mouth of the channel. In this location, CaN is advantageously placed to interact with its activator, Ca 2+ -CaM. Ca V 1.2 channels locally generate large increases in [Ca 2+ ], and they also harbor a CaM molecule at an IQ motif near the modified leucine zipper that supports interaction with AKAP79/150 (Figure 8 ). This CaM has been shown to function as the Ca 2+ sensor for L channel inactivation, facilitation, and signaling to the nucleus (Dolmetsch et al., 2001; Erickson et al., 2003; Tillotson, 1979; Zuhlke et al., 1999) . Because of its proximity and established role in L channel signaling, CaM docked at the IQ motif is an appealing candidate as an activator of anchored CaN, although alternatively, other channelassociated CaM molecules (Mori et al., 2004) may serve this function. Either way, the ability of CaM to activate calcineurin versus Ca 2+ -dependent inactivation shows pathway-specific sensitivity to Ba 2+ and BAPTA ( Figure 4 and Figure S3 ): Ba 2+ weakly mimics Ca 2+ in activating -dependent inactivation of the channel (Cens et al., 1999; Erickson et al., 2003; Tillotson, 1979; Zuhlke et al., 1999) . It is not known whether this CaM molecule, another CaM molecule associated with the channel, or free CaM activates CaN in response to Ca 2+ influx.
(B) AKAP79/150 targeting of CaN to L channels is necessary for NFATc4 activation. The known roles of CaM and PKA in nuclear signaling are also illustrated. CaM binding to the Ca V 1.2 C terminus is critical for L channel-dependent activation of CREB (Dolmetsch et al., 2001) , but the role of AKAP79/150 anchoring in PKA-dependent activation of CREB or CaN-dependent opposition to CREB phosphorylation has not been studied. Hash marks represent multiple steps and/or long distances involved in signaling pathways that affect transcription factor activation.
CaN, and 10 mM BAPTA completely suppresses activation of CaN, whereas Ba 2+ is unable to trigger Ca 2+ -dependent inactivation of Ca V 1.2, and 10 mM BAPTA has no effect on inactivation.
Given the dominance of CaN when targeted to L-type Ca 2+ channels, how is PKA ever able to succeed in influencing channel activity? We propose two possibilities. First, the results shown in Figure 4 suggest that CaN may be sensitive to the frequency of cellular excitation. CaN opposes PKA more strongly at higher excitation frequency, presumably because L channels are open more often, Ca 2+ influx is increased, and consequently CaN's phosphatase activity is increased. Thus, enhancement by PKA is likely favored when the channel is used less frequently. Second, during prolonged stimulation of CaN by Ca
2+
-CaM, oxidation of the CaN catalytic site inactivates the phosphatase Wang et al., 1996) , potentially allowing relief of CaN inhibition in response to long-lasting and/or high-frequency stimulation.
PKA enhances current amplitude by up to $500% in cardiac myocytes (Bean et al., 1984) , and our work has revealed enhancement in transfected HEK293 cells (up to $325%, Figures 3 and 4) that approaches this level. The magnitude of L channel enhancement by PKA in neurons remains unclear, but our results with cultured hippocampal neurons-an underestimate of the extent of modulation because currents were normalized to the level 1 min after the onset of forskolin application-indicate a sizeable effect ($100%, Figure 6 ) that could have profound effects on neuronal Ca 2+ signaling. If in fact maximum enhancement in neurons is limited to $100%, however, what might prevent enhancement in neurons from reaching the higher levels seen in HEK293 cells and cardiac myocytes? One possibility is that, in neurons, AKAP79/150 associates with only some channels and this subpopulation of channels is subject to substantial enhancement. This idea may also explain results from our RNAi rescue experiments that neurons overexpressing AKAP79 or AKAP79DPIX exhibited an enhanced current response to PKA stimulation, as though overexpression increases the proportion of total channels that are associated with AKAP79/150 and thus regulated by PKA and CaN. Indeed, we have previously shown that overexpression of AKAP79 in these neurons recruits additional PKA to dendritic spines (Smith et al., 2006) . Forskolin stimulation of PKA had only a small effect on L currents in cultured hippocampal pyramidal neurons unless CaN anchoring or activity was disrupted. These neurons express several AKAPs besides AKAP79/150, none of which bind CaN, and at least two of which can associate with L channels (AKAP15 [Hulme et al., 2003] and MAP2B [Davare et al., 1999] ). This requires some consideration. First, if a subset of L channels is complexed with AKAPs other than AKAP79/150, perhaps they rely upon a different phosphatase to suppress enhancement by PKA. The activity of such a phosphatase might explain how, in our experiments, PKA anchored to L channels by other AKAPs had little effect. A candidate for this role is protein phosphatase 2A, which has been reported to bind directly to the Ca V 1.2 C terminus (Davare et al., 2000; Hall et al., 2006) . Second, in L channel-AKAP complexes lacking a phosphatase, unopposed PKA may maintain channels in a maximally phosphorylated state and thereby occlude enhancement. Finally, our RNAi results suggest the possibility that AKAP79/150 is the primary AKAP associated with L-type channels in these neurons. Based on evidence that AKAP79/150 is the major AKAP in postsynaptic densities (Bauman et al., 2004) and that PKA enhances Ca 2+ influx through L channels in dendritic spines (Hoogland and Saggau, 2004) Deisseroth et al., 1996; Dolmetsch et al., 2001) . Graef et al. (1999) demonstrated that L channels also specifically activate 
EXPERIMENTAL PROCEDURES
Cell Culture and Transfections HEK293 cells were transfected with equimolar ratios of cDNAs encoding Ca V 1.2 channel subunits (a 1 1.2a, b2b, a 2 d1a) and other proteins, including AKAP79, using the Effectene transfection reagent (QIAGEN). COS7 cells were transfected by calcium phosphate precipitation. Cells were plated onto glass coverslips and studied 1-3 days after transfection.
Preparation and Transfection of Primary Hippocampal Neurons
Primary hippocampal neurons were prepared from Sprague-Dawley neonatal rats (P0-P2) as described (Gomez et al., 2002; Smith et al., 2006) . For imaging and electrophysiological recording, neurons were plated at low density (30-50,000 cells/ml) and grown 12-17 days in vitro (DIV). For IPs, neurons were plated at high density (500-750,000 cells/ml) and grown 12-17 DIV. For AMAXA-nucleofector transfection, P0-P2 neurons were resuspended at 250-500,000 cells/transfection, electroporated with 4-6 mg of each cDNA and/or the150 RNAi construct, plated at medium density, and grown to 12-17 DIV.
Immunoprecipitation
Extracts of cultured hippocampal neurons or transfected HEK293 cells were solubilized in 1.0% Triton X-100 (Gomez et al., 2002; Gorski et al., 2005) and incubated overnight at 4 C with 10 mg anti-AKAP150, anti-GFP (Molecular Probes), anti-myc (Santa Cruz) or anti-Ca V 1.2 CT4 antibodies. IPs were analyzed by immunoblotting for AKAP150 (1:2000), AKAP79 (1:1000), Ca V 1.2 (anti-CT4, 1:1000), CFP-tagged AKAP79 (anti-GFP, 1:500, Santa Cruz), or myc-tagged CaN A (antimyc 9E10, 1:1000, Santa Cruz). Chemiluminescence was detected using an Alpha-Inotech imager.
FRET Imaging
These methods and equipment have been described previously (Oliveria et al., 2003) but are described more thoroughly in Supplemental Experimental Procedures. E eff calculations are adapted from Erickson et al. (2003) .
Patch-Clamp Recording
Borosilicate patch pipettes were heat-polished to a resistance in the bath of 2-8 MU. Voltage-clamped currents were measured with an Axopatch 1D amplifier (Axon Instruments), filtered at 2 kHz, and sampled at 10 kHz. Series resistance compensation, capacitance cancellation, and leak subtraction (-P/4 protocol) were employed. For HEK293 cells, the whole-cell pipette contained (in mM): 135 CsCl, 10 EGTA or BAPTA, 10 HEPES, 4 MgATP, and pH adjusted to 7.5 with TEA-OH. The bath solution contained (in mM): 125 NaCl, 15 CaCl 2 or 15 BaCl 2 , 10 HEPES, 20 sucrose, and pH adjusted to 7.3 with TEA-OH. Ca 2+ currents were evoked by 20 ms depolarization from a holding potential of -80 mV to +10 mV every 5 s unless otherwise indicated. Current amplitudes were normalized to the steady level marked as time = 0 s, which was typically achieved 3-5 min after break-in for HEK293 cells. Positive transfectants were identified by AKAP79-YFP fluorescence. St-Ht31 (10 mM) and St-VIVIT (10 mM) were applied via rapid bath perfusion (Warner Instruments). Where indicated, FSK (5 mM), CsA (5 mM), PKI (5 mM), or CaN 457-482 (100 mM) were included in the pipette solution. For cultured hippocampal pyramidal neurons, the whole-cell pipette contained (in mM): 120 CsMeSO 4 , 30 TEA-Cl, 10 EGTA, 5 MgCl 2 , 5 Na 2 ATP, and 10 HEPES (pH 7.2). Neurons were superfused with (in mM): 125 NaCl, 10 CaCl 2 , 5.85 KCl, 22.5 TEA-Cl, 1.2 MgCl 2 , 10 HEPES(Na), 11 D-glucose (pH 7.4), as well as tetrodotoxin (TTX, 1 mM) to block Na + currents. To isolate L-type currents, N-and P/Q-type Ca 2+ channel currents were blocked by preincubating neurons in extracellular recording solution supplemented with u-conotoxins (u-CTx) GVIA (1 mM) and MVIIC (5 mM) for 30 min before recording (Tavalin et al., 2004) . Neurons were used for <1 hr after preincubation to minimize contamination from N-and P/Q-type currents as these channels became progressively unblocked (t off $200 min for u-CTx-MVIIC unbinding from P/Q-type channels [Sather et al., 1993] ; u-CTx-GVIA binding to N-type channels is even more prolonged [McCleskey et al., 1987] ). A holding potential of -60 mV was chosen to inactivate >80% of R-type channels (Sochivko et al., 2003) , which comprise 17%-35% of the total calcium current in hippocampal neurons (McDonough et al., 1996; Sochivko et al., 2003) . Transfected neurons were identified by GFP or AKAP79-GFP fluorescence. Where indicated, FSK (5 mM), CsA (5 mM), PKI (5 mM), Ht31 (10 mM), and VIVIT (10 mM) were included in the pipette solution.
For neurons, currents were normalized to the level achieved at 1 min after break-in. Only neurons with an access resistance <10 MU were studied. Cyclosporin A, forskolin, and PKI were obtained from Sigma; u-CTx-GVIA, u-CTx-MVIIC, and myr-PKI were obtained from EMD Biosciences; CaN 457-482 was obtained from Biomol; St -Ht31 and St-Ht31 pro were obtained from Promega; and St-VIVIT was synthesized by Sigma-Genosys.
Immunocytochemistry and Quantitative Digital Image Analysis
Hippocampal neurons and COS7 cells were fixed with 3.7% formaldehyde and permeabilized with 0.2% Triton X-100, as previously described (Gomez et al., 2002) . Labeling was performed with rabbit polyclonal antibodies against AKAP150 (1:500) and NFATc4 (H-74, 1:100, Santa Cruz [Groth and Mermelstein, 2003] ) and a monoclonal antibody against PSD95 (1:100, ABR). Secondary antibodies conjugated to Texas Red (1:500) or Alexa Fluor 647 (1:500) were obtained from Molecular Probes. Digital deconvolution imaging of stained cells was carried out and analyzed with Slidebook 4.0 software (Intelligent Imaging Innovations) and the same microscopy system as in the FRET experiments.
NFATc4 Translocation Assay
Prior to stimulation, coverslips bearing cultured hippocampal neurons were incubated for 3 hr at 37 C in Tyrode's solution containing (in mM):
135 NaCl, 5 KCl, 2 CaCl 2 , 1 MgCl 2 , 25 HEPES, 10 glucose, and 0.1% BSA, pH 7.4, and 1 mM TTX (Sigma). Coverslips were stimulated at room temperature with high [K + ] (90 mM) and then returned to Tyrode's + TTX and incubated at 37 C until fixation at the indicated time points.
In experiments using pharmacological manipulations, nimodipine (5 mM), myr-PKI (5 mM), or St-Ht31 (10 mM) was applied for 15 min before high [K + ] stimulation and was also included throughout the remainder of the protocol. In the EGTA-AM and BAPTA-AM experiments, after 1 hr of preincubation in Tyrode's + TTX, the bathing solution was exchanged for one containing 100 mM of either membrane-permeant chelator in addition to TTX. After 1 hr loading chelator, neurons were returned to Tyrode's + TTX and allowed to recover in this solution for 1 hr prior to stimulation with high [K + ]. To measure NFATc4 immunofluorescence intensity in a neuron, a z series (0.2 mm steps) of images was collected from each cell. The z series images were digitally deconvolved and then used to construct two-dimensional, summedintensity projection images representing the integrated intensity profile for each cell. Quantitative mask analysis of these projection images was performed using Slidebook to obtain mean immunofluorescence intensities in the nucleus and in the cytoplasm of the neuronal soma.
Statistical Analysis
All statistical analyses were performed using the Student's t test. All error bars indicate standard error of measurement.
Supplemental Data
The Supplemental Data for this article can be found online at http:// www.neuron.org/cgi/content/full/55/2/261/DC1/.
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